$518 Million is the total value of MPM ASSET MANAGEMENT LLC's 8 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ITOS | iTeos Therapeutics, Inc. | $126,694,000 | +1.1% | 3,706,663 | 0.0% | 24.48% | +38.0% | |
TCRR | TCR2 Therapeutics, Inc. | $89,443,000 | -28.6% | 4,050,865 | 0.0% | 17.28% | -2.5% | |
RPTX | Sell | Repare Therapeutics, Inc. | $79,889,000 | -22.5% | 2,603,089 | -13.3% | 15.43% | +5.9% |
DYN | Dyne Therapeutics, Inc. | $76,894,000 | -26.0% | 4,951,303 | 0.0% | 14.86% | +1.0% | |
HARP | Sell | Harpoon Therapeutics, Inc. | $67,745,000 | -9.9% | 3,238,306 | -28.4% | 13.09% | +23.1% |
ONCR | Oncorus, Inc. | $39,665,000 | -56.9% | 2,849,464 | 0.0% | 7.66% | -41.2% | |
RYTM | Sell | Rhythm Pharmaceuticals, Inc. | $19,340,000 | -65.9% | 909,258 | -52.4% | 3.74% | -53.5% |
CHMA | Chiasma, Inc. | $17,955,000 | -28.0% | 5,736,296 | 0.0% | 3.47% | -1.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Chiasma, Inc. | 24 | Q2 2021 | 19.8% |
Aratana Therapeutics, Inc. | 24 | Q1 2019 | 26.8% |
Conatus Pharmaceuticals, Inc. | 23 | Q1 2019 | 9.7% |
Rhythm Pharmaceuticals, Inc. | 19 | Q2 2022 | 69.9% |
Harpoon Therapeutics, Inc. | 19 | Q3 2023 | 31.9% |
Syndax Pharmaceuticals, Inc. | 19 | Q3 2020 | 14.5% |
Radius Health, Inc. | 17 | Q2 2018 | 76.4% |
TCR2 Therapeutics, Inc. | 17 | Q1 2023 | 29.1% |
Proteon Therapeutics, Inc. | 17 | Q4 2018 | 3.0% |
EpiZyme, Inc. | 15 | Q4 2016 | 35.9% |
View MPM ASSET MANAGEMENT LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR/A | 2023-09-07 |
13F-HR | 2023-08-14 |
4 | 2023-06-05 |
4 | 2023-05-24 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-11 |
View MPM ASSET MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.